Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
9.15
+0.18 (2.01%)
Sep 10, 2026, 10:54 AM EDT - Market open
Xilio Therapeutics Market Cap
Xilio Therapeutics has a market cap or net worth of $60.21 million as of September 10, 2026. Its market cap has increased by 54.89% in one year.
Market Cap
60.21M
Enterprise Value
-69.53M
1-Year Change
54.89%
Ranking
Category
Stock Price
$9.15
ChartMarket Cap Chart
Since the IPO on October 22, 2021, Xilio Therapeutics's market cap has decreased from $426.71M to $60.21M, a decrease of -85.89%. That is a compound annual growth rate of -33.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 60.21M | 79.13% |
| Dec 31, 2025 | 33.61M | -19.94% |
| Dec 31, 2024 | 41.98M | 177.26% |
| Dec 29, 2023 | 15.14M | -79.46% |
| Dec 30, 2022 | 73.73M | -83.14% |
| Dec 31, 2021 | 437.33M | 2.49% |
| Oct 22, 2021 | 426.71M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Serina Therapeutics | 63.50M |
| MindWalk Holdings | 63.43M |
| Elicio Therapeutics | 61.76M |
| eXoZymes | 58.57M |
| MiNK Therapeutics | 58.43M |
| ImageneBio | 57.32M |
| Hyperion DeFi | 55.63M |
| Annovis Bio | 55.39M |